Skip to content

Price / book at other companies

Intel logo
IntelINTC
+1.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
2.7×-7.2×
Mobileye Global Inc. logo
Mobileye Global Inc.MBLY
0.7×-0.3×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
3.4×+1.6×
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
174.8×+171×

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Calculated from Rafael Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s price / book?
Rafael Holdings, Inc. (RFL) reported price / book of 0.9× in Q1 2026.
How has Rafael Holdings, Inc.'s price / book changed year-over-year?
Rafael Holdings, Inc.'s price / book increased by 12.4% year-over-year, from 0.8× to 0.9×.
What is the long-term trend for Rafael Holdings, Inc.'s price / book?
Over 4 years (2021 to 2025), Rafael Holdings, Inc.'s price / book has grown at a -44.9% compound annual growth rate (CAGR), from 6.8× to 0.6×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.